Nuray is an expert in the synthesis of Niche novel APIs, the first to launch Generics, NCEs, Advanced Intermediates // USFDA certified.
Reset all filters
01 2Nuray Chemicals Private Limited
02 1Biophore India Pharmaceuticals Pvt Ltd
03 1Neuland Laboratories
04 1Alivus Life Sciences
05 1Aurobindo Pharma Limited
06 1Aurore Life Sciences
07 2Cipla
08 1MSN Laboratories
09 1Saptagir Laboratories
10 1Sun Pharmaceutical Industries Limited
11 1Teva Pharmaceutical Industries
Reset all filters
01 10TAFAMIDIS
02 1TAFAMIDIS (CC)
03 1TAFAMIDIS (FORM-4)
04 1TAFAMIDIS (I)
Reset all filters
01 12India
02 1Israel
Reset all filters
01 13Active
Reset all filters
01 8Complete
02 5Blank
Nuray is an expert in the synthesis of Niche novel APIs, the first to launch Generics, NCEs, Advanced Intermediates // USFDA certified.
GDUFA
DMF Review : Complete
Rev. Date : 2020-11-01
Pay. Date : 2020-09-15
DMF Number : 35067
Submission : 2020-09-18
Status : Active
Type : II
Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.
GDUFA
DMF Review : Complete
Rev. Date : 2023-03-31
Pay. Date : 2023-03-21
DMF Number : 37694
Submission : 2022-11-30
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 38240
Submission : 2023-03-31
Status : Active
Type : II
Nuray is an expert in the synthesis of Niche novel APIs, the first to launch Generics, NCEs, Advanced Intermediates // USFDA certified.
GDUFA
DMF Review : Complete
Rev. Date : 2023-03-28
Pay. Date : 2023-02-08
DMF Number : 36953
Submission : 2023-02-08
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 37523
Submission : 2023-03-27
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 37480
Submission : 2022-10-18
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2023-03-13
Pay. Date : 2023-01-25
DMF Number : 37686
Submission : 2022-11-28
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2023-03-03
Pay. Date : 2023-01-25
DMF Number : 37667
Submission : 2022-12-28
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2023-05-15
Pay. Date : 2023-04-10
DMF Number : 34736
Submission : 2020-03-30
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2023-01-19
Pay. Date : 2022-11-18
DMF Number : 37717
Submission : 2023-01-05
Status : Active
Type : II
98
PharmaCompass offers a list of Tafamidis API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Tafamidis manufacturer or Tafamidis supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Tafamidis manufacturer or Tafamidis supplier.
PharmaCompass also assists you with knowing the Tafamidis API Price utilized in the formulation of products. Tafamidis API Price is not always fixed or binding as the Tafamidis Price is obtained through a variety of data sources. The Tafamidis Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A 2-(3,5-Dichlorophenyl)-1,3-Benzoxazole-6-Carboxylic Acid manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of 2-(3,5-Dichlorophenyl)-1,3-Benzoxazole-6-Carboxylic Acid, including repackagers and relabelers. The FDA regulates 2-(3,5-Dichlorophenyl)-1,3-Benzoxazole-6-Carboxylic Acid manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. 2-(3,5-Dichlorophenyl)-1,3-Benzoxazole-6-Carboxylic Acid API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of 2-(3,5-Dichlorophenyl)-1,3-Benzoxazole-6-Carboxylic Acid manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A 2-(3,5-Dichlorophenyl)-1,3-Benzoxazole-6-Carboxylic Acid supplier is an individual or a company that provides 2-(3,5-Dichlorophenyl)-1,3-Benzoxazole-6-Carboxylic Acid active pharmaceutical ingredient (API) or 2-(3,5-Dichlorophenyl)-1,3-Benzoxazole-6-Carboxylic Acid finished formulations upon request. The 2-(3,5-Dichlorophenyl)-1,3-Benzoxazole-6-Carboxylic Acid suppliers may include 2-(3,5-Dichlorophenyl)-1,3-Benzoxazole-6-Carboxylic Acid API manufacturers, exporters, distributors and traders.
click here to find a list of 2-(3,5-Dichlorophenyl)-1,3-Benzoxazole-6-Carboxylic Acid suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A 2-(3,5-Dichlorophenyl)-1,3-Benzoxazole-6-Carboxylic Acid DMF (Drug Master File) is a document detailing the whole manufacturing process of 2-(3,5-Dichlorophenyl)-1,3-Benzoxazole-6-Carboxylic Acid active pharmaceutical ingredient (API) in detail. Different forms of 2-(3,5-Dichlorophenyl)-1,3-Benzoxazole-6-Carboxylic Acid DMFs exist exist since differing nations have different regulations, such as 2-(3,5-Dichlorophenyl)-1,3-Benzoxazole-6-Carboxylic Acid USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A 2-(3,5-Dichlorophenyl)-1,3-Benzoxazole-6-Carboxylic Acid DMF submitted to regulatory agencies in the US is known as a USDMF. 2-(3,5-Dichlorophenyl)-1,3-Benzoxazole-6-Carboxylic Acid USDMF includes data on 2-(3,5-Dichlorophenyl)-1,3-Benzoxazole-6-Carboxylic Acid's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The 2-(3,5-Dichlorophenyl)-1,3-Benzoxazole-6-Carboxylic Acid USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of 2-(3,5-Dichlorophenyl)-1,3-Benzoxazole-6-Carboxylic Acid suppliers with USDMF on PharmaCompass.
We have 11 companies offering 2-(3,5-Dichlorophenyl)-1,3-Benzoxazole-6-Carboxylic Acid
Get in contact with the supplier of your choice: